1. Agid, Y., Parkinson’s disease: pathophysiology, Lancet, 1991, vol. 337, no. 8753, pp. 1321–1324.
2. D’Amato, R.J., Lipman, Z.P., and Snyder, S.H., Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin, Science, 1986, vol. 231, no. 4741, pp. 987–989.
3. Andrianova, E.L., Pro- and anti-apoptotic effect of neurolypins on normal and transformed cells of the nervous system, Extended Abstract of Cand. Sci. (Chem.) Dissertation, Moscow, 2009.
4. Anglade, P., Vyas, S., Hirsch, E., and Agid, Y., Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging, Histol. Histopathol., 1997, vol. 12, no. 3, pp. 603–610.
5. Bessmel’tsev, S.S., Kozlov, A.V., Syasina, T.V., and Udal’eva, V.Yu., Comparative evaluation of methods for determining apoptotic activity of bone marrow cells in patients with chronic myelogenous leukemia, Fundam. Issled., 2011, no. 10 (1), pp. 33–36.